Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
  Cancer vaccine enhanced, non-tumor-reactive CD8(+) T cells exhibit a distinct molecular program associated with "division arrest anergy"

Beyer, M., Karbach, J., Mallmann, M. R., Zander, T., Eggle, D., Classen, S., et al. (2009). Cancer vaccine enhanced, non-tumor-reactive CD8(+) T cells exhibit a distinct molecular program associated with "division arrest anergy". Cancer research, 69(10), 4346-54. doi:10.1158/0008-5472.CAN-08-3796.

Item is

Dateien

einblenden: Dateien
ausblenden: Dateien
:
Beyer-2009-Cancer vaccine enhan.pdf (beliebiger Volltext), 632KB
 
Datei-Permalink:
-
Name:
Beyer-2009-Cancer vaccine enhan.pdf
Beschreibung:
-
OA-Status:
Sichtbarkeit:
Privat
MIME-Typ / Prüfsumme:
application/pdf
Technische Metadaten:
Copyright Datum:
-
Copyright Info:
-
Lizenz:
-

Externe Referenzen

einblenden:
ausblenden:
externe Referenz:
http://www.ncbi.nlm.nih.gov/pubmed/19435912 (beliebiger Volltext)
Beschreibung:
-
OA-Status:
externe Referenz:
http://cancerres.aacrjournals.org/content/69/10/4346.full.pdf (beliebiger Volltext)
Beschreibung:
-
OA-Status:

Urheber

einblenden:
ausblenden:
 Urheber:
Beyer, M., Autor
Karbach, J., Autor
Mallmann, M. R., Autor
Zander, T., Autor
Eggle, D., Autor
Classen, S., Autor
Debey-Pascher, S., Autor
Famulok, M.1, Autor
Jäger, E., Autor
Schultze, J. L., Autor
Affiliations:
1External Organizations, ou_persistent22              

Inhalt

einblenden:
ausblenden:
Schlagwörter: CD8-Positive T-Lymphocytes/*cytology/*immunology Cancer Vaccines/therapeutic use Cell Division/immunology Chemokines, C/genetics Clonal Anergy/*immunology Gene Expression Profiling HLA-A2 Antigen/immunology Humans Immunophenotyping Lymphocyte Culture Test, Mixed Lymphocyte Depletion Neoplasms/*genetics/*immunology Oligonucleotide Array Sequence Analysis Reverse Transcriptase Polymerase Chain Reaction
 Zusammenfassung: Immune-mediated tumor rejection relies on fully functional T-cell responses and neutralization of an adverse tumor microenvironment. In clinical trials, we detected peptide-specific but non-tumor-reactive and therefore not fully functional CD8(+) T cells post-vaccination against tumor antigens. Understanding the molecular mechanisms behind nontumor reactivity will be a prerequisite to overcome this CD8(+) T-cell deviation. We report that these non-tumor-reactive CD8(+) T cells are characterized by a molecular program associated with hallmarks of "division arrest anergy." Non-tumor-reactive CD8(+) T cells are characterized by coexpression of CD7, CD25, and CD69 as well as elevated levels of lck(p505) and p27(kip1). In vivo quantification revealed high prevalence of non-tumor-reactive CD8(+) T cells with increased levels during cancer vaccination. Furthermore, their presence was associated with a trend toward shorter survival. Dynamics and frequencies of non-target-reactive CD8(+) T cells need to be further addressed in context of therapeutic vaccine development in cancer, chronic infections, and autoimmune diseases.

Details

einblenden:
ausblenden:
Sprache(n):
 Datum: 2009
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Identifikatoren: Anderer: 19435912
DOI: 10.1158/0008-5472.CAN-08-3796
ISSN: 1538-7445 (Electronic)
ISSN: 0008-5472 (Linking)
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: Cancer research
  Alternativer Titel : Cancer Res.
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: -
Seiten: - Band / Heft: 69 (10) Artikelnummer: - Start- / Endseite: 4346 - 54 Identifikator: -